Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q2 2023 Earnings Call Transcript August 25, 2023
Akebia Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.06, expectations were $0.025.
Operator: Good day and welcome to Akebia’s Second Quarter 2023 Financial Results Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session and instructions will be given at that time. As a reminder this call is being...
